Related Experiment Video
Updated: Jul 2, 2025
Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
Published on: August 17, 2022
Causal effects between circulating immune cells and heart failure: evidence from a bidirectional Mendelian
Rutao Bian1,2, Xuegong Xu3,4,5, Zishuang Li1,2
1Zhengzhou Hospital of Traditional Chinese Medicine, Zhengzhou, China.
Insights
Higher lymphocyte counts may reduce heart failure risk. Specifically, increased CD39+ CD4+ T-cells are linked to a lower risk of heart failure (HF), suggesting a causal relationship.
Area of Science:
- Immunology
- Cardiovascular Medicine
- Genetics
Background:
- Heart failure (HF) is a significant cause of mortality and morbidity.
- Immune cells are key biomarkers for immune status.
- The causal link between circulating immune cells and HF pathogenesis needs more research.
Purpose of the Study:
- Investigate genetic interactions between circulating immune cells and HF.
- Elucidate genetic associations between lymphocyte subsets and HF.
Main Methods:
- Utilized two-sample and multivariate Mendelian randomization (MVMR).
- Employed inverse variance weighting (IVW) and sensitivity analyses.
- Obtained genetic variants from the Blood Cell Consortium and HF data.
Main Results:
- Elevated lymphocyte count showed a correlation with decreased HF risk (OR = 0.97).
- Increased CD39+ CD4+ T-cell counts were significantly linked to reduced HF risk (OR = 0.96).
- MVMR confirmed the significant association for CD39+ CD4+ T-cells and HF.
Conclusions:
- Mendelian randomization (MR) research supports a causal link between lymphocytes and HF.
- Specific subset analysis revealed a causal relationship between CD39+ CD4+ T lymphocytes and HF.
- Findings aid future understanding of HF mechanisms.
Background:
Heart failure (HF) is a prevalent cardiac condition characterized by high mortality and morbidity rates. Immune cells play a pivotal role as crucial biomarkers in assessing the overall immune status of individuals. However, the causal relationship between circulating immune cells and the pathogenesis of HF remains an area requiring further investigation.
Objectives:
The aim of this study was to investigate the genetic interactions between circulating immune cells and HF, and to further elucidate the genetic associations between different lymphocyte subsets and HF.
Methods:
We obtained genetic variants associated with circulating immune cells as instrumental variables (IVs) from the Blood Cell Consortium and publicly available HF summary data. We conducted additional subsets analyses on lymphocyte counts. Our study utilized two-sample and multivariate Mendelian randomization (MVMR) analysis to investigate the causal effect of immune cells on HF. The primary analysis employed inverse variance weighting (IVW) and was complemented by a series of sensitivity analyses.
Results:
The findings of the study showed that the IVW model demonstrated a significant correlation between an elevation in lymphocyte count and a decreased risk of HF (OR = 0.97, 95% CI, 0.94 - 1.00, P = 0.032). However, no such correlation was evident in the MVMR analysis for lymphocytes and HF. Furthermore, the examination of the lymphocyte subsets indicated that an increase in CD39+ CD4+ T-cell counts was notably linked to a reduced risk of HF (OR = 0.96, 95% CI, 0.95 - 0.98, P = 0.0002). The MVMR results confirmed that the association between CD39+ CD4+ T-cell counts and HF remained significant. There was no substantial evidence of reverse causality observed between circulating immune cells and HF.
Conclusion:
Our MR research provided evidence for a causal relationship between lymphocyte cell and HF. Subsets analyses revealed a causal relationship between CD39+ CD4+ T lymphocytes and HF. These findings will facilitate a future understanding of the mechanisms underlying HF.
More Related Videos
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
08:22Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart
Published on: April 15, 2020
